Clinical Trials

200 enrolled

Thoracic

Carcinoma, Non-Small-Cell Lung

NCT05422521 2024-01-30

CART-Omic

20 enrolled

Lymphoid

Lymphoma, Non-Hodgkin

NCT04253080 2024-01-09

ENZYMELA

170 enrolled

Dermatologic

Diabetes Mellitus, Insulin-Dependent, 12, Melanoma

NCT02977052 2023-11-15

OpACIN-neo

Phase 2 Unknown

186 enrolled

Dermatologic

Melanoma

NCT06046963 2023-09-21

Sintilimab in Combination With S-1/Oxaliplatin With Nab-paclitaxel Intraperitoneal Infusion for Untreated Advanced Gastric Cancer With Malignant Ascites

Phase 2 Unknown

35 enrolled

Ascites, Stomach Neoplasms

NCT06020651 2023-08-31

VICKI

Urinary Bladder Neoplasms, Carcinoma, Renal Cell, Neoplasms, Vascular Diseases, Atherosclerosis

NCT03806764 2023-06-01

CReSCT

370 enrolled

Cytomegalovirus Infections, Virus Diseases, Hematologic Neoplasms

NCT03189576 2023-05-26

Measuring Molecular Residual Disease in Colorectal Cancer After Primary Surgery and Resection of Metastases

37 enrolled

Colorectal Neoplasms, Neoplasm, Residual

NCT05099237 2023-05-03

EMBRaCE-GM

80 enrolled

GastrointestinalThoracic

Lung Neoplasms, Colorectal Neoplasms

NCT03313544 2023-04-21

Evolution of the Heart Function When Monitoring Immunotherapies Anti-cancerous Inhibiting PD-1

Phase 4 Unknown

DermatologicThoracic

Lung Neoplasms, Melanoma

NCT05793021 2023-03-31

FKBP51s: a New Molecular Biomarker for Glioblastoma? Pre- and Post-operative Blood Levels Evaluation of FKBP51s Protein and Correlation With MRI Phenotype

70 enrolled

CNS

Glioblastoma

NCT05714592 2023-02-22

MYELOCARTOCH

300 enrolled

Myeloid

Myeloproliferative Disorders

NCT04680117 2022-10-31

SevAsthma

150 enrolled

Lymphoid

Asthma, Lymphoma, Follicular

NCT05062096 2022-10-04

NAKIMEL

220 enrolled

Dermatologic

Melanoma

NCT02843763 2022-08-02

TRAK

70 enrolled

Neoplasms

NCT03985696 2022-07-25

ExoReBLy

90 enrolled

Lymphoid

Lymphoma

NCT05099068 2022-07-05

PLANET

CNSLymphoidOther hematologic neoplasm

500 enrolled

Glioblastoma, Leukemia, B-Cell

NCT04948840 2022-06-23

TREM-1

20 enrolled

Breast Neoplasms, Fibrosis, Radiation Injuries

NCT05426317 2022-06-22

Onco-PDL1s/B2M

DermatologicGenitourinaryThoracic

100 enrolled

Carcinoma, Non-Small-Cell Lung, Kidney Neoplasms, Melanoma

NCT05099211 2022-06-21

REMUSCLON

60 enrolled

Colonic Neoplasms

NCT03978702 2022-01-06

IMMUNOPANC

Hyperglycemia, Pancreatic Neoplasms

NCT05119244 2021-11-15

PPE

150 enrolled

Thoracic

Marijuana Abuse, Lung Neoplasms

NCT03256084 2021-05-06

Tumoral Circulating Cells and Colorectal Cancer Progression

120 enrolled

Colorectal Neoplasms

NCT04822974 2021-03-30

TTV-CART

20 enrolled

Hematologic Neoplasms

NCT04774133 2021-03-01

The Immunodynamic Effect of Radiotherapy in Prostate Cancer Patients.

Prostatic Neoplasms

NCT02342158 2021-01-22

PERMED01

550 enrolled

Neoplasm Metastasis

NCT04279509 2020-09-09

Selecting Chemotherapy With High-throughput Drug Screen Assay Using Patient Derived Organoids in Patients With Refractory Solid Tumours (SCORE)

GastrointestinalGynecologicHead & Neck

35 enrolled

Squamous Cell Carcinoma of Head and Neck, Carcinoma, Ovarian Epithelial, Colorectal Neoplasms

NCT01440413 2020-03-24

BREAST IMMUN

Breast Neoplasms, Recurrence

NCT03150121 2020-02-26

BEDOCA

500 enrolled

Gynecologic

Fallopian Tube Neoplasms, Ovarian Neoplasms, Cystadenocarcinoma, Serous

NCT02613962 2020-02-17

MAPPYACTS

700 enrolled

Neoplasms, Recurrence

NCT02963155 2020-01-10

NKPROSTATE

30 enrolled

Neoplasm Metastasis, Prostatic Neoplasms

NCT03185039 2020-01-10

Predictive Impact of MMP2 and MMP9 Levels for Patients With Metastatic Kidney Cancer Treated With Anti-angiogenic Agents

Kidney Neoplasms

NCT03946943 2019-07-10

Study of Anlotinib Hydrochloride and Toripalimab in Subjects With Unresectable or Metastatic Undifferentiated Pleomorphic Sarcoma

Phase 2 Unknown

25 enrolled

Sarcoma

Sarcoma, Histiocytoma, Malignant Fibrous

NCT03964922 2019-05-28

EVADE

104 enrolled

Neoplasms

NCT03935672 2019-05-02

PEARL

Head & Neck

Oropharyngeal Neoplasms

NCT03771404 2018-12-11

NSCLC Heterogeneity in Early Stage Patients and Prediction of Relapse Using a Personalized "Liquid Biopsy"

Thoracic

Carcinoma, Non-Small-Cell Lung

NCT03631836 2018-08-17

MARELLE01

Phase 1 Unknown

34 enrolled

CNS

Glioblastoma

NCT03567044 2018-06-25

Immune Effects in Patients Treated With Whole Breast Irradiation

Breast Neoplasms

NCT03401359 2018-01-17

The Resistance and Immune Response to Palbociclib in Breast Cancer

100 enrolled

Breast Neoplasms

NCT03357978 2017-11-30

Susceptibility to Infections, Tumor Risk and Liver Disease in Patients With Ataxia Telangiectasia

30 enrolled

Ataxia Telangiectasia, Immunologic Deficiency Syndromes, Liver Diseases

NCT03337516 2017-11-09

Interest of a Therapeutic Follow-up of the Cytarabine in the Acute Myeloid Leukaemia: Is There Constitutional Biomarkers

Leukemia, Myeloid, Acute

NCT02345915 2017-09-05

LEA-JA

LymphoidOther hematologic neoplasm

90 enrolled

Leukemia, Myeloid, Acute, Precursor Cell Lymphoblastic Leukemia-Lymphoma

NCT02666612 2017-01-26

Liquid Biopsy

2,240 enrolled

Neoplasm Metastasis

NCT02875990 2016-08-23

Xac03

Gynecologic

Uterine Cervical Neoplasms

NCT01786889 2016-07-29

ANGIHE

9 enrolled

Sarcoma

Hemangiosarcoma

NCT02105168 2016-06-10

MSN

2,200 enrolled

DermatologicThoracic

Carcinoma, Non-Small-Cell Lung, Melanoma, Small Cell Lung Carcinoma

NCT02539472 2016-04-18

DIAPREMYF

620 enrolled

DermatologicLymphoid

Lymphoma, T-Cell, Cutaneous

NCT02489929 2015-07-03

Evaluation of Cytidine Deaminase for Patient Suffering of a Myelodysplastic Syndrom or an AML Treated by Azacytidine

MyeloidOther hematologic neoplasm

35 enrolled

Leukemia, Myeloid, Myelodysplastic Syndromes

NCT01915992 2014-09-01

Natural Killer Cells Functions, Tumoral Escape to Immune System and Regulation of Natural Cytotoxixity Receptors in Haematological Malignancies

15 enrolled